Author

Eugeni Domenech Morral

Mistakes in the management of postoperative Crohn’s disease and how to avoid them
Mistakes in the management of postoperative Crohn’s disease and how to avoid them

Eugeni Domenech Morral  et al.

THE ADDITION OF HIGH-DOSE INTRAVENOUSBOLUS OF METHYL-PREDNISOLONE INCREASES THE EARLY CLINICAL RESPONSE TO ORAL CORTICOSTEROIDS IN MODERATELY ACTIVE ULCERATIVE COLITIS. PRELIMINARY RESULTS OF A PROSPECTIVE, CONTROLLED, MULTICENTRE, RANDOMISED, OPEN-LABEL
THE ADDITION OF HIGH-DOSE INTRAVENOUSBOLUS OF METHYL-PREDNISOLONE INCREASES THE EARLY CLINICAL RESPONSE TO ORAL CORTICOSTEROIDS IN MODERATELY ACTIVE ULCERATIVE COLITIS. PRELIMINARY RESULTS OF A PROSPECTIVE, CONTROLLED, MULTICENTRE, RANDOMISED, OPEN-LABEL

UEG Webinar | Mistakes in the management of postoperative Crohn’s disease and how to avoid them
UEG Webinar | Mistakes in the management of postoperative Crohn’s disease and how to avoid them

Eugeni Domenech Morral  et al.

MORBID OBESITY, A NEW SUSCEPTIBILITY FACTOR FOR DEVELOPING INFLAMMATORY BOWEL DISEASE. RESULTS OF A POPULATION-BASED STUDY
MORBID OBESITY, A NEW SUSCEPTIBILITY FACTOR FOR DEVELOPING INFLAMMATORY BOWEL DISEASE. RESULTS OF A POPULATION-BASED STUDY

Eugeni Domenech Morral  et al.

CAN HOSPITAL ADMISSIONS FOR LOWER GASTROINTESTINAL BLEEDING BE REDUCED? IMPLEMENTATION OF TWO SCALES FOR THE PREDICTION OF SAFETY DISCHARGE IN A RETROSPECTIVE COHORT
CAN HOSPITAL ADMISSIONS FOR LOWER GASTROINTESTINAL BLEEDING BE REDUCED? IMPLEMENTATION OF TWO SCALES FOR THE PREDICTION OF SAFETY DISCHARGE IN A RETROSPECTIVE COHORT

Eugeni Domenech Morral  et al.

MANAGEMENT AND OUTCOMES OF LOWER GASTROINTESTINAL BLEEDING IN PATIENTS ON ANTICOAGULATION
MANAGEMENT AND OUTCOMES OF LOWER GASTROINTESTINAL BLEEDING IN PATIENTS ON ANTICOAGULATION

Eugeni Domenech Morral  et al.

LINKING LOCATION SPECIFIC GENE EXPRESSION PATTERNS TO POTENTIAL VEDOLIZUMAB OUTCOMES IN CROHN’S DISEASE PATIENTS
LINKING LOCATION SPECIFIC GENE EXPRESSION PATTERNS TO POTENTIAL VEDOLIZUMAB OUTCOMES IN CROHN’S DISEASE PATIENTS

Eugeni Domenech Morral  et al.

UNDERSTANDING THE IMPACT OF PREVIOUS TNF-ALPHA INHIBITORS ON VEDOLIZUMAB RESPONSE IN PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE USING SYSTEMATIC REVIEW AND GENE EXPRESSION DATA
UNDERSTANDING THE IMPACT OF PREVIOUS TNF-ALPHA INHIBITORS ON VEDOLIZUMAB RESPONSE IN PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE USING SYSTEMATIC REVIEW AND GENE EXPRESSION DATA

Eugeni Domenech Morral  et al.

LONG-TERM RISK OF DELAYED POSTOPERATIVE CROHN’S DISEASE RECURRENCE IN PATIENTS WITH NO OR MILD RECURRENCE AT FIRST ENDOSCOPIC ASSESSMENT
LONG-TERM RISK OF DELAYED POSTOPERATIVE CROHN’S DISEASE RECURRENCE IN PATIENTS WITH NO OR MILD RECURRENCE AT FIRST ENDOSCOPIC ASSESSMENT

Eugeni Domenech Morral  et al.

CAP-SUCTION UNDERWATER ENDOSCOPIC MUCOSAL RESECTION (CAP-UEMR) AS AN EASY-TO-USE AND EFFICIENT TECHNIQUE FOR TREATING FLAT COMPLEX COLORECTAL LESIONS: A PROOF OF CONCEPT PILOT STUDY
CAP-SUCTION UNDERWATER ENDOSCOPIC MUCOSAL RESECTION (CAP-UEMR) AS AN EASY-TO-USE AND EFFICIENT TECHNIQUE FOR TREATING FLAT COMPLEX COLORECTAL LESIONS: A PROOF OF CONCEPT PILOT STUDY

Eugeni Domenech Morral  et al.

PATHOLOGIC INVOLVEMENT OF THE FARNESOID X RECEPTOR/FIBROBLAST GROWTH FACTOR 19 AXIS TO THE CROHN’S DISEASE EARLY POSTSURGICAL RECURRENCE
PATHOLOGIC INVOLVEMENT OF THE FARNESOID X RECEPTOR/FIBROBLAST GROWTH FACTOR 19 AXIS TO THE CROHN’S DISEASE EARLY POSTSURGICAL RECURRENCE

Eugeni Domenech Morral  et al.

CHARACTERIZATION OF THE FATTY ACID PROFILE OF THE CREEPING FAT OF CROHN’S DISEASE IN COMPARISON TO INFLAMMATORY BOWEL DISEASE-FREE CONTROLS
CHARACTERIZATION OF THE FATTY ACID PROFILE OF THE CREEPING FAT OF CROHN’S DISEASE IN COMPARISON TO INFLAMMATORY BOWEL DISEASE-FREE CONTROLS

Eugeni Domenech Morral  et al.

THE ADDITION OF HIGH-DOSE INTRAVENOUSBOLUS OF METHYL-PREDNISOLONE INCREASES THE EARLY CLINICAL RESPONSE TO ORAL CORTICOSTEROIDS IN MODERATELY ACTIVE ULCERATIVE COLITIS. PRELIMINARY RESULTS OF A PROSPECTIVE, CONTROLLED, MULTICENTRE, RANDOMISED, OPEN-LABEL
THE ADDITION OF HIGH-DOSE INTRAVENOUSBOLUS OF METHYL-PREDNISOLONE INCREASES THE EARLY CLINICAL RESPONSE TO ORAL CORTICOSTEROIDS IN MODERATELY ACTIVE ULCERATIVE COLITIS. PRELIMINARY RESULTS OF A PROSPECTIVE, CONTROLLED, MULTICENTRE, RANDOMISED, OPEN-LABEL

Eugeni Domenech Morral  et al.

REAL-LIFE EXPERIENCE OF THE EFFICACY, SAFETY AND PHARMACOKINETIC DATA OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB IN INACTIVE INFLAMMATORY BOWEL DISEASE PATIENTS. RESULTS FROM THE ENEIDA REGISTRY
REAL-LIFE EXPERIENCE OF THE EFFICACY, SAFETY AND PHARMACOKINETIC DATA OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB IN INACTIVE INFLAMMATORY BOWEL DISEASE PATIENTS. RESULTS FROM THE ENEIDA REGISTRY

Eugeni Domenech Morral  et al.

CLINICAL OUTCOMES IN FAMILIAL VERSUS SPORADIC INFLAMMATORY BOWEL DISEASE DIAGNOSED IN THE ERA OF BIOLOGICAL THERAPIES. PROSPECTIVE DATA FROM THE ENEIDA REGISTRY
CLINICAL OUTCOMES IN FAMILIAL VERSUS SPORADIC INFLAMMATORY BOWEL DISEASE DIAGNOSED IN THE ERA OF BIOLOGICAL THERAPIES. PROSPECTIVE DATA FROM THE ENEIDA REGISTRY

Eugeni Domenech Morral  et al.

EFFECTIVENESS AND SAFETY OF USTEKINUMAB IN ULCERATIVE COLITIS: REAL WORLD EVIDENCE FROM ENEIDA REGISTRY
EFFECTIVENESS AND SAFETY OF USTEKINUMAB IN ULCERATIVE COLITIS: REAL WORLD EVIDENCE FROM ENEIDA REGISTRY

Eugeni Domenech Morral  et al.

ACCELERATED OR ESCALATED INDUCTION REGIMENS OF INFLIXIMAB FOR STEROID-REFRACTORY ACUTE SEVERE ULCERATIVE COLITIS IN CLINICAL PRACTICE: DATA FORM THE ENEIDA REGISTRY
ACCELERATED OR ESCALATED INDUCTION REGIMENS OF INFLIXIMAB FOR STEROID-REFRACTORY ACUTE SEVERE ULCERATIVE COLITIS IN CLINICAL PRACTICE: DATA FORM THE ENEIDA REGISTRY

Eugeni Domenech Morral  et al.

USTEKINUMAB AND VEDOLIZUMAB AS FIRST-LINE BIOLOGICAL THERAPY FOR INFLAMMATORY BOWEL DISEASE IN CLINICAL PRACTICE. A MULTICENTER STUDY BASED ON THE ENEIDA REGISTRY
USTEKINUMAB AND VEDOLIZUMAB AS FIRST-LINE BIOLOGICAL THERAPY FOR INFLAMMATORY BOWEL DISEASE IN CLINICAL PRACTICE. A MULTICENTER STUDY BASED ON THE ENEIDA REGISTRY

Eugeni Domenech Morral  et al.

TOFACITINIB IN ULCERATIVE COLITIS: REAL WORLD EVIDENCE FROM ENEIDA REGISTRY
TOFACITINIB IN ULCERATIVE COLITIS: REAL WORLD EVIDENCE FROM ENEIDA REGISTRY

Eugeni Domenech Morral  et al.

PERFORMANCE OF SCREENING STRATEGIES FOR LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY OF GETECCU
PERFORMANCE OF SCREENING STRATEGIES FOR LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY OF GETECCU

Eugeni Domenech Morral  et al.

Item 1 - 20 / 28
1
2